Melina is passionate about innovation in healthcare, biotechnology, and synthetic biology. Through positions at Merck and Genentech, she honed her industry experience in areas ranging from RNA therapeutics to portfolio planning. She has also worked closely with a number of startup founders to help them reach their goals as a consultant with Oxbridge Biotech Roundtable and Biotech Connection Bay Area. During the course of her Ph.D. studies at Stanford University, she developed novel molecular tools for engineering biology and was selected as an Accel Innovation Scholar and a Siebel Scholar. At AMV, she leverages her background to cover digital health and the life sciences.
Melina is currently a Ph.D. candidate in Bioengineering at Stanford University. She holds a Master’s degree in Bioengineering from Stanford University and a Bachelor’s degree in Molecular and Cell Biology from UC Berkeley.
AMV is a venture capital firm investing in
early-stage digital health, technology and
life sciences companies.
2100 Geng Road, Suite 200
Palo Alto, CA
© 2017 Asset Management Ventures
All Rights Reserved